Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Credit: doucefleur/Adobe Stock

Public attitudes about pharmaceutical companies have improved significantly during the pandemic, and litigators are gearing up to deal with that trend in the courtroom.

Some attorneys who file drug defect suits expect that drug company lawyers will seek to bask in the glow of their newfound public esteem at upcoming pharmaceutical trials.

This premium content is locked for
Insurance Coverage Law Center subscribers only.

Start a free trial to enjoy unlimited access to the single source of objective legal analysis, practical insights, and news for the insurance industry.

  • Access the most current expert analysis and daily developments across jurisdictions
  • Solve complex research issues with expert tools and intelligence
  • Tap into insurance coverage expert guidance

Already have an account?
For enterprise-wide or corporate access, please contact our Sales Department at 1-800-543-0874 or email [email protected].


Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.